To provide practical recommendations for imaging in the diagnosis and management of fibrotic lung diseases (FLDs), emphasizing the impact on patient outcomes.
Key Findings:
High-resolution chest CT is the most accurate non-invasive method for diagnosing pulmonary fibrosis, essential for effective management.
CT scans should be performed with specific technical requirements to ensure quality imaging, impacting diagnostic accuracy.
Subtle interstitial lung abnormalities can worsen over time and should be monitored closely to prevent disease progression.
Quantitative CT methods show promise in evaluating disease progression but are not yet routine, indicating a need for further research.
Interpretation:
The recommendations emphasize the importance of high-resolution CT in diagnosing and managing FLDs, highlighting the need for early detection and appropriate imaging techniques to improve patient outcomes.
Limitations:
Level of evidence for many recommendations is low, which may affect their implementation in clinical practice.
Quantitative CT methods are not routinely employed in clinical practice, limiting their current utility.
Conclusion:
The paper provides essential imaging criteria for the diagnosis and management of fibrotic lung diseases, aiming to improve patient outcomes through early detection and appropriate treatment strategies.
by Anna Rita Larici, Juergen Biederer, Giuseppe Cicchetti, Tomas Franquet Casas, Nick Screaton, Martine Remy-Jardin, Anagha Parkar, Helmut Prosch, Cornelia Schaefer-Prokop, Thomas Frauenfelder, Benoit Ghaye, Nicola Sverzellati
